News and Analysis ONI snaps up $75m Series B ONI, a biotechnology company, has secured $75 million in Series B financing. Iris Dorbian - 20 January 2022 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in